Lemtrada (alemtuzumab) is an FDA-approved infusion therapy for relapsing forms of MS. It's considered a highly effective disease-modifying therapy (DMT). The infusion schedule is unique compared to other MS infusions:
- Year 1: Given over five consecutive days
- Year 2: Another round given over three consecutive days, one Show Full Answer
Lemtrada (alemtuzumab) is an FDA-approved infusion therapy for relapsing forms of MS. It's considered a highly effective disease-modifying therapy (DMT). The infusion schedule is unique compared to other MS infusions:
- Year 1: Given over five consecutive days
- Year 2: Another round given over three consecutive days, one year later
Because of its risks, Lemtrada is only available through a restricted distribution program to ensure proper safety monitoring. There are some important risks to be aware of before considering Lemtrada:
- Increased risk of infections
- Potential for other autoimmune complications
- Allergic or infusion reactions
- In rare cases (about 2.6% of people), a blood platelet condition can develop around 24 months after the first treatment
It's worth having a detailed conversation with your neurologist about whether Lemtrada is the right fit for your specific situation, symptoms, and treatment goals. On the positive side, many MyMSTeam members have shared encouraging experiences with DMT infusions overall. One MyMSTeam member said, *"I get so excited when my infusions come around — they give me hope and really help me."*
If cost is a concern, copay assistance programs are available for Lemtrada. Ask your neurologist's office or a social worker to help find the right program for you.
June 23
Join
Your Privacy Choices
